CATALYST PHARMACEUTICALS INC earnings per share and revenue

CN2 earnings per share for the last quarter are 0.31 EUR whereas the estimation was 0.27 EUR which accounts for 15.13% surprise. Company revenue for the same period amounts to 113.55 M EUR despite the estimated figure of 110.84 M EUR. Estimated earnings per share for the next quarter are 0.32 EUR, and revenue is expected to reach 126.92 M EUR. Also watch annual changes over time to get a bigger picture of CN2 earnings per share and revenue dynamics.